Universe Pharmaceuticals (UPC) Invested Capital (2021 - 2026)

Universe Pharmaceuticals has reported Invested Capital for 6 years, with the latest figure at $7.4 million in Q1 2026.

• Quarterly Invested Capital changed N/A year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 billion (changed N/A YoY) and the FY2025 annual result came in at $7.1 million, down 99.88% from the prior year.
• Invested Capital climbed to $7.4 million in Q1 2026 per UPC's latest filing, from $7.1 million in the prior quarter.
• Over five years, Invested Capital peaked at $5.9 billion in Q3 2024 and troughed at $3.4 million in Q3 2022.
• A 5-year average of $980.8 million and a median of $6.3 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2024 and 2025: Invested Capital jumped 106726.27% in 2024, then plunged 99.88% in 2025.
• Over 5 years, Invested Capital stood at $3.4 million in 2022, then surged by 62.24% to $5.5 million in 2023, then surged by 106726.27% to $5.9 billion in 2024, then slumped by 99.88% to $7.1 million in 2025, then increased by 3.2% to $7.4 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $7.4 million, $7.1 million, and $5.9 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.